cdmo.directory
← Compare landing

Merck KGaA vs Sambi Pharma

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryMerck KGaASambi Pharma
SummaryRecent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.Sambi Pharma offers process research and development, manufacturing, and analytical quality control services, alongside Fmoc-amino acid and specialty chemical products. Listed facilities are in Hyderabad, India, including an IDA Mallapur works site.
ServicesData not yet provided.
  • Small Molecule Development & Manufacturing
  • Process Development
  • Quality Control Testing
ModalitiesData not yet provided.Data not yet provided.
Development capabilitiesData not yet provided.Data not yet provided.
Manufacturing capabilitiesData not yet provided.Data not yet provided.
Locations
  • Daejeon Bioprocessing Center, Daejeon, South Korea
  • Prashanti Hills office, Hyderabad, India
  • IDA Mallapur works, Hyderabad, India
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Merck KGaA alternatives · Sambi Pharma alternatives

Markdown mirror: /compare/merck-kgaa/sambipharma.md